Participants with Type 2 diabetes lost 19.7% but gained the additional benefit of 2.02% A1C reduction, bringing average A1C from 8.1% to 6.08%
Developed by Theratechnologies Inc., it underwent phase II trials in the mid-2000s for GH deficiency (GHD) and HIV lipodystrophy but was discontinued, with reported reasons including hypersensitivity reactions, including an anaphylaxis-like reaction in one trial participant Wong et al (2008) [Note: Abstract only
Each bottle contains 60 capsules, providing a 100-calorie (420 kJ) boost from vegetable sources
Our Approach Each peptide program includes: Comprehensive medical consultation Hormonal, metabolic, and mitochondrial testing Review of genetics, sleep, and lifestyle factors Personalized peptide protocols Ongoing medical monitoring and optimization To learn more or schedule a longevity consultation, visit www.centerforadvancedurology.com.
Frequently Asked Questions Is feeling cold a sign that semaglutide is working